https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2022.786451/full
Frontiers | Assessment of Molecular Residual Disease Using Circulating Tumor DNA to Identify...
Background: Despite treatment with high-dose chemotherapy followed by autologous stem cell transplantation (AHCT), patients with multiple myeloma (MM) invari...
molecular residual diseasecirculating tumor dna
https://www.mayo.edu/research/clinical-trials/cls-20583362
Surgical Drain Fluid For Detection Of Molecular Residual Disease For HPV(-) Head And Neck Cancers -...
Learn more about services at Mayo Clinic.
https://www.marketscreener.com/quote/stock/MYRIAD-GENETICS-INC-10141/news/Myriad-Genetics-Forms-5-Year-Alliance-With-MD-Anderson-to-Evaluate-Molecular-Residual-Disease-Assay-48698692/
Myriad Genetics Forms 5-Year Alliance With MD Anderson to Evaluate Molecular Residual Disease Assay...
Jan 7, 2025 - Myriad Genetics and the University of Texas MD Anderson Cancer Center said Tuesday that they formed a five-year strategic alliance to accelerate the clinical...